Evidence map›Paper›PMID 40257568›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Anchor-Away: Efficient, Conditional Depletion of Nuclear Proteins in Saccharomyces cerevisiae.

Ke Xu, Valérie Côté, Jacques Côté

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ke XuSt-Patrick Research Group in Basic Oncology, Laval University Cancer Research Center, Oncology Division of the Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Quebec City, QC, Canada.
Valérie CôtéSt-Patrick Research Group in Basic Oncology, Laval University Cancer Research Center, Oncology Division of the Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Quebec City, QC, Canada.
Jacques CôtéSt-Patrick Research Group in Basic Oncology, Laval University Cancer Research Center, Oncology Division of the Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Quebec City, QC, Canada. jacques.cote@crchudequebec.ulaval.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For functional studies of proteins in cells, effective tools that trigger rapid and efficient inactivation of the proteins are indispensable. The anchor-away (AA) system is designed to deplete nuclear-localized proteins through cellular relocation. The target protein is sequestered by an anchor receptor protein from the nucleus to the cytoplasm. The depletion is achieved through the formation of a stable complex that is solely driven by the addition of rapamycin, between the FRB domain of human mTOR and the FKBP12-binding domain of the FRP protein. The target protein and the receptor protein are fused through genetic recombination with the FRB and FKBP12 domains, respectively, to mediate the interaction. The export of the nuclear protein of interest is executed by the receptor protein, i.e., ribosomal protein RPL13A, which is transiently imported into the nucleus and then exported to the cytoplasm within the pre-ribosome. The proteins of interest can be depleted within minutes although the depleting conditions need to be optimized. AA is a valuable tool to help dissect the biological functions of nuclear proteins, especially ones that are essential for cell viability. In this chapter, we describe the steps to construct the necessary strains and several biochemical and functional experiments to confirm the functional abrogation of target proteins by AA.

Indexed as

Nuclear ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsCell NucleusCytoplasmHumansRibosomal ProteinsSirolimusTacrolimus Binding Protein 1ATOR Serine-Threonine KinasesMTOR protein, humanNuclear ProteinsRibosomal ProteinsSaccharomyces cerevisiae ProteinsSirolimusTacrolimus Binding Protein 1ATOR Serine-Threonine KinasesAnchor-awayConditional depletionNuclear proteinRapamycin-inducedSaccharomyces cerevisiaeYeast

Identifiers

PMID40257568

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.